Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer, prostat

Lentaron) gosetelin USP [65807-02-5] C59Hg4NigOi4 1269.43 (63) postmenopausal breast cancer prostatic carcinoma bone pain common... [Pg.443]

Schwarze SR, Luo J, Isaacs WB, Jarrard DF. Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 2005 13 13. [Pg.334]

Vaday GG, Peehl DM, Kadam PA, Lawrence DM. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006 66 124-134. [Pg.347]

Barber, NJ, X Zhang, G Zhu et al. 2006. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis 9 407 -13. [Pg.459]

Miki, J and JS Rhim. 2007. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis 11(1 ) 32—39. [Pg.462]

Miyata, Y, H Sakai, T Hayashi, and H Kanetake. 2003. Serum insulin-like growth factor binding protein-3/ prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer. Prostate 54 125-132. [Pg.462]

Haddad AQ, Venkateswaran V, Viswanathan L, Teahan SJ, Fleshner NE and Klotz LH. 2006. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 9(l) 68-76. [Pg.171]

Cancer is one of the most devastating diseases. Even though a few cancer types are associated with a particular gender (e.g., ovarian cancer, prostate cancer), the onset usually takes place regardless of age, sex, and race. Although cancer prevention remains the ideal approach to eradicate the disease, the best second option is early detection. [Pg.332]

Estrogens, estrone (28.1.9), estradiol (28.1.17), ethynylestradiol (28.1.26), diethylstilbe-strol (28.1.33), and chlorotrianisene (30.5.2), are used for palliative treatment of postmenopausal breast cancer, prostate cancer, and breast cancer in men. It is highly probable that the mechanism of action is similar to the mechanism of action of androgens. [Pg.409]

Kuzmin, and R. R. Amdiy. Early urodynamic effects of the lipido-ste-rolic extract of Serenoa repens (Permixon ) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2000 3(3) 195-199. [Pg.478]

Docetaxel Inhibits mitosis Breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancer, ovarian cancer, bladder cancer Hypersensitivity Neurotoxicity, fluid retention, myelosuppression with neutropenia... [Pg.1176]

In addition to deciding that there was sufficient evidence for associations between herbicides and five diseases, the IOM committee concluded thatthere was limited/suggestive evidence for associations with respiratory cancer, prostate cancer—the two most common cancers in males—and multiple myeloma. IOM relied upon studies of chemical plant workers to decide that dioxin was associated with respiratory cancer, and in particular upon a study of U.S. chemical plant workers.32... [Pg.219]

Hong JH, Aim KS, Bae E, Jeon SS, Choi HY. 2006. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 9 147-152. [Pg.390]

Steers WD, Kirby RS. Clinical ease of using doxazosin in BPH patients with and without hypertension. Prostate Cancer Prostatic Dis. 2005 8 152-157. [Pg.305]

Strohmeyer, D., Rossing, C., Bauerfeind, A., Kaufmann, O., Schlechte, H., Bartsch, G., andlxrening, S. 2000. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate 45, 216-224. [Pg.163]

Bharaj BB, Luo LY, Jung K, Stephan C, Diamandis EP. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK 10) gene and their association with prostate, breast, testicular, and ovarian cancers. Prostate 2002 51 35 11. [Pg.67]

Yousef GM, Stephan C, Scorilas A, et al. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate 2003 56 287-292. [Pg.80]

FMCa Flavonols Flavones Flavanones 24-26-28 9131 M-F Reduction of total mortality, lung cancer, prostate cancer arthritis, asthma, coronary heart disease (161-163)... [Pg.227]

Isaacs JT, et al. (2006) Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. Prostate 66(16) 1768-1778... [Pg.228]

Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S. Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer. Prostate 1999 39(2) 123-129. [Pg.101]

Jr GW, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, Schellhammer PF, Gong L, Vlahou A (1999) Pro-teinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 2(5/6) 264-276... [Pg.872]

A7. Aral, Y., Yoshiki, T., and Yoshida, O., c-erbB-2 oncoprotein A potential biomarker of advanced prostate cancer. Prostate 30, 195-201 (1997). [Pg.141]

H15. Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H., and Hittmair, A., Androgen receptor status of lymph node metastases from prostate cancer. Prostate 28, 129-135 (1996). [Pg.148]

K18. Kubota Y., Shuin, T., Uemura, H., Fujinami, K., Miyoto, H., et at, Tumor suppressor gene p53 mutations in human prostate cancer. Prostate 27, 18-24 (1995). [Pg.150]

W3. Wang, Y. Z., and Wong, Y. C., Sex hormone-induced prostatic carcinogenesis in die noble rat die role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 35, 165—177 (1998). [Pg.158]

W7. Wikstrom, P., Stattin, P., Franck-Lissbrandt, I., Damber, J. E., and Bergh, A., Transforming growth factor beta 1 is associated with angiogenesis, metastasis, and poor outcome in prostate cancer. Prostate 37, 19-29 (1998). [Pg.159]


See other pages where Cancer, prostat is mentioned: [Pg.257]    [Pg.793]    [Pg.344]    [Pg.187]    [Pg.188]    [Pg.100]    [Pg.168]    [Pg.408]    [Pg.256]    [Pg.178]    [Pg.109]    [Pg.358]    [Pg.68]    [Pg.241]    [Pg.412]    [Pg.560]    [Pg.213]    [Pg.83]    [Pg.614]    [Pg.110]    [Pg.135]    [Pg.142]   
See also in sourсe #XX -- [ Pg.246 ]




SEARCH



3-Carotene prostate cancer risk

Adenocarcinoma prostate cancer

Alkylating agents prostate cancer

Aminoglutethimide in prostate cancer

Androgen receptor prostate cancer

Androgen receptor, in prostate cancer

Androgens prostate cancer

Angiogenesis prostate cancer

Antiandrogens in prostate cancer

Bicalutamide in prostate cancer

Bicalutamide prostate cancer

Biomarker for prostate cancer

Biopsies, prostate cancer

Brachytherapy, prostate cancer

Cancer Lymphomas Malignancies Prostate

Cancer clusters prostate

Cancer of prostate

Cancer of the prostate

Cancer prostate-specific antigen

Cancer prostatic acid phosphatase

Cancer prostatic, treatment

Cancer therapy prostate

Cancer, breast prostate

Cancer, breast prostate gland

Carotenoids against prostate cancer

Castrate-resistant prostate cancer

Castration-resistant prostate cancer

Chemotherapy in prostate cancer

China prostate cancer

Curcumin prostate cancer inhibited

Cyproterone prostatic cancer

Docetaxel prostate cancer

Doxorubicin prostate cancer

Epidermal growth factor receptor prostate cancer

Estrogen receptor , prostate cancer

Flaxseed prostate cancer

Flutamide in prostate cancer

Genistein prostate cancer

Goserelin in prostate cancer

Human prostate cancer

Human prostate cancer cells

INDEX prostate cancer

Invasion prostate cancer

Japan prostate cancer

Ketoconazole in prostate cancer

LNCaP human prostate cancer cell

Lignans prostate cancer

Lupron Depot prostate cancer

Lycopene prostate cancer

MRI Compatible Device for Robotic Assisted Interventions to Prostate Cancer

Metastasis of prostate cancer

Metastasis prostate cancer

Metastatic castration-resistant prostate cancer

Mitoxantrone prostate cancer

Monotherapy prostate cancer

OncoVax against prostate cancer

Ornithine decarboxylase prostate cancer

PC3 prostate cancer cells

Pamidronate in prostate cancer

Platinum complexes prostate cancer

Prednisone in prostate cancer

Prostate Cancer Detection

Prostate Cancer Prevention Trial

Prostate Cancer Prevention Trial (PCPT

Prostate Cancer Prevention Trial vitamin

Prostate DU145 cancer cells

Prostate cancer

Prostate cancer

Prostate cancer 5 alpha-reductase

Prostate cancer Gleason score

Prostate cancer LHRH agonists

Prostate cancer aberrations

Prostate cancer about

Prostate cancer against

Prostate cancer androgen synthesis inhibitors

Prostate cancer antiandrogens

Prostate cancer apoptosis

Prostate cancer benign hyperplasia

Prostate cancer bisphosphonates

Prostate cancer case study

Prostate cancer cells

Prostate cancer chemotherapy

Prostate cancer clinical presentation

Prostate cancer corticosteroids

Prostate cancer curcumin

Prostate cancer cyproterone acetate

Prostate cancer deprivation)

Prostate cancer diagnosis

Prostate cancer dietary factors

Prostate cancer dietary fiber

Prostate cancer digital rectal examination

Prostate cancer economics

Prostate cancer enzalutamide

Prostate cancer epidemiology

Prostate cancer estrogen therapy

Prostate cancer etiology

Prostate cancer evaluation

Prostate cancer expectant management

Prostate cancer expression

Prostate cancer finasteride

Prostate cancer gene amplification

Prostate cancer genetic factors

Prostate cancer grading

Prostate cancer hormonal manipulations

Prostate cancer hormonal regulation

Prostate cancer hormonal therapy

Prostate cancer hormone-refractory

Prostate cancer hormone-related

Prostate cancer hyperplasia

Prostate cancer incidence rate

Prostate cancer lycopene, protective effect

Prostate cancer manipulator

Prostate cancer metastasis role

Prostate cancer metastatic

Prostate cancer monoclonal antibodies

Prostate cancer mortality

Prostate cancer mortality from

Prostate cancer mortality rate

Prostate cancer mutations

Prostate cancer needle biopsy

Prostate cancer outcome evaluation

Prostate cancer overview

Prostate cancer palliative therapy

Prostate cancer pathophysiology

Prostate cancer phosphorylation

Prostate cancer phytoestrogens

Prostate cancer precision

Prostate cancer prediction

Prostate cancer pretreatment

Prostate cancer prevention

Prostate cancer prevention role of lycopene

Prostate cancer prognosis

Prostate cancer prognostic marker

Prostate cancer proliferation mechanisms

Prostate cancer prostatic acid phosphatase

Prostate cancer proteomic studies

Prostate cancer radiation therapy

Prostate cancer results

Prostate cancer sample preparation

Prostate cancer staging

Prostate cancer stromal tissue

Prostate cancer surgery

Prostate cancer surgical

Prostate cancer therapeutic modulation

Prostate cancer therapeutic targeting

Prostate cancer tissue

Prostate cancer treatment

Prostate cancer values

Prostate cancer watchful waiting

Prostate cancer, advanced hormone-resistant

Prostate cancer, carotenoids

Prostate cancer, immunotherapy

Prostate cancer, incidence

Prostate cancer, polymer-paclitaxel

Prostate cancer, polymer-paclitaxel formulation

Prostate cancer, role

Prostate cancer/tumors

Prostatectomy in prostate cancer

Prostatic cancer

Prostatic cancer

Prostatic cancer animals

Prostatic cancer humans

Staging of prostate cancer

Subject prostate cancer

Suramin, patients with prostate cancer

Tomatoes prostate cancer

Transforming growth factor prostate cancer

Tumor markers prostate cancer

Urokinase-type plasminogen activator prostate cancer

Vitamin prostate cancer

Zoledronate in prostate cancer

© 2024 chempedia.info